Molecular Diagnostics Market will experience a noticeable growth during the forecast period 2018- 2023: Orion Market Reports

Orion Market Research (OMR) recently published a market research report on the global Molecular Diagnostics Market. According to OMR analysis, the global molecular diagnostics market is estimated to grow at a significant CAGR during the forecast period (2018-2023). The crucial factor driving the growth of the market includes considerable rise in the prevalence of infectious diseases and cancer. In addition, the growing demand for cost-effective and accurate diagnostic solutions is further propelling the growth of the market.

A full report of the global molecular diagnostics market is available at

https://www.omrglobal.com/industry-reports/molecular-diagnostics-market/

Furthermore, the global molecular diagnostics market is segmented on the basis of technology, product, application and end-user. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

Market Segmentation

1.      Global Molecular Diagnostics Market by Technology

·        Polymerase Chain Reaction (PCR)

·        In Situ Hybridization (ISH)

·        Mass Spectrometry (MS)

·        DNA Microarray

·        Next-Generation Sequencing (NGS)

·        Transcription Mediated Amplification

·        Isothermal Nucleic Acid Amplification

2.      Global Molecular Diagnostics Market by Product

·        Testing instruments

·        Diagnostic Reagents and Kits

3.      Global Molecular Diagnostics Market by Application

·        Infectious Diseases

·        Cancer

·        Cardiovascular Disease

·        Genetic Testing

·        Forensic Science

·        Neurological Disease

·        Other (Microbiology)

4.      Global Molecular Diagnostics Market by End-User

·        Hospitals

·        Diagnostic Centres

·        Research Institute

Visit here to know more about Molecular Diagnostics Market study.

Region Covered

•                 North America (US and Canada)

•                 Europe (United Kingdom, Germany, France, Spain, and Italy)

•                 Asia-Pacific (China, India, South Korea, and Japan)

•                 Rest of the World (Middle East & Africa and Latin America)

Company Profiled

·        Abbott Laboratories, Inc.

·        Agilent Technologies, Inc.

·        AltheaDX, Inc.

·        AutoGenomics, Inc.

·        Becton Dickinson and Co.

·        Biocartis N.V.

·        bioMérieux SA

·        Bio-Rad Laboratories, Inc.

·        CareDX, Inc.

·        Danaher Corp.

·        ELITech Group

·        F. Hoffmann-La Roche Ltd.

·        Genetic Technologies, Ltd.

·        GenMark Diagnostics, Inc.

·        Genomic Health, Inc.

For free sample request please visit: https://www.omrglobal.com/request-sample/?id=18914

The key objectives of the Molecular Diagnostics study:

·        To analyze the Molecular Diagnostics Market size (values and volume) by segments with historical data of 2017 and 2018 and forecast to 2025.

·        To study the key factors influencing the growth of the market.

·        Focuses on the key leaders to define and analyze the sales volume, value, share, competitive landscapes, SWOT analysis, and development plans.

·        To analyze the Molecular Diagnostics Market growth, global trends, future prospectus and contribution to the market.

Related Reports:

·        Surgical Simulation Market

·        Hemostasis Valves Market

Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com       
Contact no: +1 646-755-7667, +91 780-304-0404